• Home
  • Pharmacy Medical Policy Updates

Pharmacy Medical Policy Updates

The following Pharmacy Medical Policy program has been updated March 1, 2023:

Effective April 1, 2023:

  • Ampyra
  • Multiple Sclerosis
  • Healthcare Administered Multiple Sclerosis
  • Kerendia
  • Opzelura
  • Spinraza
  • SA Oncology
  • Tezspire
  • Zeposia

Many of our pharmacy medical policies are maintained through our pharmacy benefit manager, Prime Therapeutics.

To find pharmacy medical policies specific to a medication list, please select a medication list at the bottom of our prior authorization page of our website, https://www.bcbsks.com/providers/precertification-prior-authorization

If you have any questions regarding this newsletter, please contact your BCBSKS provider representative/consultant.

Institutional Providers
Professional Providers